MyAverix Finance
V · Healthcare
LSL Pharma Group Inc. (LSL)
Drug Manufacturers - Specialty & Generic
LSL Pharma Group Inc. (LSL) is listed on V in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LSL
LSL Pharma Group Inc. (LSL) — FAQ
What is LSL's P/E ratio?
The price-to-earnings (P/E) ratio for LSL Pharma Group Inc. (LSL) is 18.00 (data as of 2026-03-22).
Does LSL Pharma Group Inc. pay a dividend?
Dividend yield is not available in the current snapshot for LSL Pharma Group Inc. (LSL). Check the MyAverix Finance app for the latest dividend data.
What sector is LSL Pharma Group Inc. in?
LSL Pharma Group Inc. (LSL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LSL listed on?
LSL is listed on V.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.